Your browser doesn't support javascript.
loading
A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials.
Whiteaker, Jeffrey R; Zhao, Lei; Schoenherr, Regine M; Huang, Dongqing; Lundeen, Rachel A; Voytovich, Ulianna; Kennedy, Jacob J; Ivey, Richard G; Lin, Chenwei; Murillo, Oscar D; Lorentzen, Travis D; Colantonio, Simona; Caceres, Tessa W; Roberts, Rhonda R; Knotts, Joseph G; Reading, Joshua J; Perry, Candice D; Richardson, Christopher W; Garcia-Buntley, Sandra S; Bocik, William; Hewitt, Stephen M; Chowdhury, Shrabanti; Vandermeer, Jackie; Smith, Stephen D; Gopal, Ajay K; Ramchurren, Nirasha; Fling, Steven P; Wang, Pei; Paulovich, Amanda G.
Afiliação
  • Whiteaker JR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Zhao L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Schoenherr RM; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Huang D; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Lundeen RA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Voytovich U; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Kennedy JJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Ivey RG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Lin C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Murillo OD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Lorentzen TD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Colantonio S; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
  • Caceres TW; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
  • Roberts RR; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
  • Knotts JG; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
  • Reading JJ; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
  • Perry CD; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
  • Richardson CW; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
  • Garcia-Buntley SS; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
  • Bocik W; Cancer Research Technology Program, Antibody Characterization Lab, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
  • Hewitt SM; Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD, United States.
  • Chowdhury S; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Vandermeer J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Smith SD; Division of Medical Oncology, Department of Internal Medicine, University of Washington, Seattle, WA, United States.
  • Gopal AK; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Ramchurren N; Division of Medical Oncology, Department of Internal Medicine, University of Washington, Seattle, WA, United States.
  • Fling SP; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Wang P; Division of Medical Oncology, Department of Internal Medicine, University of Washington, Seattle, WA, United States.
  • Paulovich AG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Front Oncol ; 13: 1168710, 2023.
Article em En | MEDLINE | ID: mdl-37205196
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos